Ora

What is the Prognosis for ASML?

Published in Stock Prognosis 1 min read

The prognosis for ASML is generally positive, with analysts indicating a "Moderate Buy" consensus and significant potential for price appreciation over the next 12 months.

Analyst Consensus and Price Target

Based on recent analyst ratings, ASML Holding (ASML) is viewed favorably, with a majority recommending buying the stock. The collective outlook suggests a healthy growth trajectory.

  • Consensus Rating: Moderate Buy
  • Average 12-Month Price Target: $878.65
  • Upside Potential: 23.71%

This average price target suggests a considerable increase from current levels, indicating strong confidence in the company's future performance.

Rating Breakdown

The "Moderate Buy" consensus is derived from a detailed breakdown of individual analyst recommendations:

Rating Number of Analysts
Buy 5
Hold 2
Sell 0

The absence of "Sell" ratings further reinforces the positive sentiment surrounding ASML, highlighting that no analysts currently anticipate a decline in the stock's value. The predominant "Buy" ratings underscore the belief in ASML's continued strength in the market, driven by its critical role in the semiconductor industry.

[[ASML Stock Outlook]]